Calithera Biosciences (CALA) Stock Price, News & Analysis

0.00 (0.00%)
(As of 05/17/2024 ET)
Today's Range
50-Day Range
52-Week Range
87 shs
Average Volume
1,169 shs
Market Capitalization
P/E Ratio
Dividend Yield
Price Target
CALA stock logo

About Calithera Biosciences Stock (NASDAQ:CALA)

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

CALA Stock Price History

CALA Stock News Headlines

Calithera Biosciences (NASDAQ:CALA) Now Covered by
Arcus Biosciences Inc (RCUS)
Christina Cala
CALA - Calithera Biosciences, Inc.
Cala Mariolu
Cala Llombards
Calithera Biosciences to Liquidate >CALA
See More Headlines
Receive CALA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Calithera Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Fiscal Year End

Industry, Sector and Symbol

Pharmaceutical preparations
Current Symbol
Year Founded


Pretax Margin


Sales & Book Value

Annual Sales
$9.75 million
Book Value
($0.40) per share


Free Float
Market Cap
Not Optionable

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Ms. Stephanie Wong (Age 50)
    CFO & Secretary
    Comp: $752.42k
  • Dr. Christopher J. Molineaux Ph.D. (Age 71)
    Senior Vice President of Development
    Comp: $405k
  • Mr. Frank Parlati Ph.D. (Age 55)
    Senior Vice President of Research

CALA Stock Analysis - Frequently Asked Questions

How have CALA shares performed in 2024?

Calithera Biosciences' stock was trading at $0.03 at the beginning of 2024. Since then, CALA shares have decreased by 33.3% and is now trading at $0.02.
View the best growth stocks for 2024 here

How were Calithera Biosciences' earnings last quarter?

Calithera Biosciences, Inc. (NASDAQ:CALA) posted its quarterly earnings results on Monday, November, 8th. The biotechnology company reported ($3.00) EPS for the quarter, beating the consensus estimate of ($4.60) by $1.60. The biotechnology company had revenue of $6.75 million for the quarter. During the same period last year, the firm posted ($6.40) EPS.

When did Calithera Biosciences' stock split?

Calithera Biosciences shares reverse split on Wednesday, June 15th 2022. The 1-20 reverse split was announced on Wednesday, June 15th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Calithera Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Calithera Biosciences investors own include Puma Biotechnology (PBYI), Incyte (INCY), BioMarin Pharmaceutical (BMRN), (MDVN) (MDVN), Celadon Group (CGI), Dynavax Technologies (DVAX), Rigel Pharmaceuticals (RIGL), First Solar (FSLR), Plug Power (PLUG) and Sorrento Therapeutics (SRNE).

How do I buy shares of Calithera Biosciences?

Shares of CALA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CALA) was last updated on 5/19/2024 by Staff

From Our Partners